Sign In
Buy FAMDF
$0.0090
-0.0004 (-4.66%)
At Close: Jun 03, 2026
Futura Medical formally appoints interim chief executive as sales review gets under way
02:46am, Friday, 08'th Aug 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has formally appointed Alex Duggan as interim chief executive, following the completion of regulatory checks. Duggan, who brings more than 25 years of leadershi
Futura Medical unveils boardroom shakes up
02:42am, Tuesday, 08'th Jul 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF) said its chair and chief executive have stepped down, with a new interim CEO earmarked to take the reins in August. In a statement on Tuesday, the company said
Futura Medical targets 20 markets for Eroxon - ICYMI
05:19am, Friday, 18'th Apr 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder talked with Proactive about the company's 2024 financial performance, market expansion, and its product pipeline. Futura Medical PLC reported a
Futura Medical beats forecasts as Eroxon heads for 20-country rollout
03:33am, Tuesday, 15'th Apr 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has reported full-year results ahead of market expectations, as demand for its flagship product, Eroxon, gathers pace across international markets. The company
Futura Medical brings on new board member
02:43am, Monday, 31'st Mar 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF), the company behind the sexual health product Eroxon, has just added a new face to its board. Harmesh Suniara has joined as a non-executive Director, starting s
Futura Medical ends 2024 on a high; outlook lower for current year
03:16am, Thursday, 30'th Jan 2025
Futura Medical PLC (AIM:FUM, OTC:FAMDF) says its 2024 revenue and profit were ahead of market expectations, driven by the strong launch of its erectile dysfunction gel, Eroxon. Sales reached at least
Futura Medical shares boosted by update on potential breakthrough product
07:12am, Wednesday, 15'th Jan 2025
Shares in Futura Medical PLC (AIM:FUM, OTC:FAMDF)rose 5% on Wednesday after the company reported positive results from a sensory study of WSD4000, its gel treatment for female sexual dysfunction. The
Futura Medical ticking all the boxes - but has the market caught up?
06:58am, Monday, 04'th Nov 2024
In investment circles, a company's inflexion points - key developments that can drive growth - often signal a rise in stock price. For Futura Medical PLC (AIM:FUM, OTC:FAMDF), several such events have
Futura Medical provides a glimpse of the future with two new products planned
03:03am, Monday, 04'th Nov 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has announced positive developments for two prospective sexual health products, aiming to broaden its lineup and target both men's and women's health needs. Th
Futura Medical shares rise on $5m US milestone payment
03:55am, Monday, 07'th Oct 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) shares rose 3% in early trading after the company secured a $5 million milestone payment following the US launch of its erectile dysfunction gel, Eroxon. The p
Futura Medical in line for $5m milestone payment as Haleon's US Eroxon launch gets underway
02:25am, Monday, 07'th Oct 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured a $5 million milestone payment following the US launch of its flagship product, Eroxon. The payment was triggered as Haleon, the company's distribu
Futura Medical consensus increases materially
03:05am, Thursday, 12'th Sep 2024
Analysts following Futura Medical PLC (AIM:FUM, OTC:FAMDF) have updated and significantly upgraded revenue forecasts in the wake of its better-than-expected interims - results that saw the sexual hea
Futura Medical CEO talks Eroxon growth and US launch - ICYMI
11:48am, Wednesday, 11'th Sep 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder talked with Proactive about the company's interim results, which included a maiden profit, along with the outlook for the business. The sexual
Futura Medical: Doing what it says on the tube, says investment bank
05:20am, Wednesday, 11'th Sep 2024
'Doing what it says on the tube', was the headline from a Panmure Liberum report in the wake of Futura Medical PLC (AIM:FUM, OTC:FAMDF)'s interim results. In summary, the numbers represented a landmar
Futura posts maiden profit ahead of time; says revenue and earnings will 'significantly' exceed expectations
02:53am, Tuesday, 10'th Sep 2024
Futura Medical PLC (AIM:FUM, OTC:FAMDF) may have one eye on the upcoming US launch of its fast-acting erectile dysfunction gel Eroxon by healthcare giant Haleon. However, its financial performance in
